HOME >> MEDICINE >> NEWS
Cost control measures limit patient and physician choice in psychotropic medications

Waltham, MA A new Brandeis University study published online in Clinical Therapeutics suggests that private health plans increasingly rely on escalating copayments to manage drug costs, as opposed to administrative controls. This makes treatment more expensive in many cases for patients, and may affect adherence to treatment, said lead author Dominic Hodgkin, associate professor at the Schneider Institute for Behavioral Health, Heller School for Social Policy and Management at Brandeis University.

In the past decade, health insurers have increasingly turned to cost controls to manage prescription drug use, but little is known about how such policies affect the use of psychotropic drugs, said Hodgkin. Between 1996 and 2001, psychotropic drug use to treat psychiatric disorders climbed from 5.9 percent to 8.1 percent of the U.S. population. Newer, better tolerated drugs account for some of the growth; however, because they are often more expensive than more established treatments, psychotropic drug spending has skyrocketed, from an estimated $3.7 billion in 1991 to $18 billion in 2001.

"This growth has raised concern among public and private health care payers, who have responded with cost-containment policies that affect the choices of patients and physicians," explained Hodgkin. The study evaluated brand antidepressants, antipsychotics and drugs used to treat attention-deficit hyperactivity disorder (ADHD).

Medicaid programs, by contrast, rely on administrative controls to manage psychotropic drug costs. These controls include prior authorization by a physician before a patient can switch to a non-preferred drug at the same copayment level. Further complicating the picture, patient non-compliance rates are high for psychotropic drugs such as antidepressants and treatments for schizophrenia.

The study evaluated a nationally representative survey of private health plans regarding mental health and substance abuse services. Most pl
'"/>

Contact: Laura Gardner
gardner@brandeis.edu
781-736-4204
Brandeis University
1-Mar-2007


Page: 1 2

Related medicine news :

1. Chromatin remodeling complex connected to DNA damage control
2. New research discovers independent brain networks control human walking
3. Study says normal but out-of-control enzyme may be culprit that signals some cells to become cancer
4. Study shows Diachrome improves blood sugar control in people with type 2 diabetes
5. Bias in statin trials, failure to control malaria, and more
6. VA tops private hospitals in infection-control study
7. Survey shows asthma not controlled in majority of patients
8. Sling surgery is more effective than Burch for bladder control in women
9. To get blood pressure under control, combination of medicines may be best
10. Animal study leading to new treatments for hemorrhagic shock and uncontrolled abdominal hemorrhage
11. Asthma study shows patients have more options to control disease

Post Your Comments:
(Date:3/3/2015)... March 03, 2015 Longtime parent visionary ... CARE Surrogacy Center for a candid interview ... appearing online is an exhilarating revelation of his magical ... led him from Australia to the birth of his ... interchange, Tolga Umar, CEO and Founder of CARE stated, ...
(Date:3/3/2015)... 03, 2015 Dan E. Chambers, an experienced ... focus on capital crimes, recently spoke on the radio to ... The hosts of the Independent Journal Review radio show “The ... first as a prosecutor and now as a criminal defense ... made in the trial and sentencing of this high-profile case. ...
(Date:3/3/2015)... The report “Alopecia – Pipeline Review, H1 2015? ... Alopecia is the loss of hair. Alopecia areata and ... Causes for alopecia include aging, genetics, illness, chemotherapy, malnutrition ... pattern hair loss, female diffuse hair loss, hairs easily ... focal or diffuse and by the presence or absence ...
(Date:3/3/2015)... The first week of March is ... The event brings recognition to a rarely discussed problem ... According to the Centers for Disease Control , 70 ... or another. Too little or unrestful sleep is associated ... and depression, and even a higher likelihood of obesity. ...
(Date:3/3/2015)... The combinatorial, multi-gene GeneSight test ... outcomes for patients with depression, and their use ... individual genes that comprise the test, according to ... Clinic and Assurex Health, and published online by ... technology of the GeneSight Psychotropic test is based ...
Breaking Medicine News(10 mins):Health News:CARE Surrogacy Center Mexico Conducts Candid Interview with Australian Father of Twins 2Health News:CARE Surrogacy Center Mexico Conducts Candid Interview with Australian Father of Twins 3Health News:Dan E. Chambers Gives Radio Interview Providing Insights into American Sniper Guilty Verdict 2Health News:Dan E. Chambers Gives Radio Interview Providing Insights into American Sniper Guilty Verdict 3Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 2Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 3Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 4Health News:Medicationdiscountcard.com recognizes sleep awareness week with discounts on sleep meds including Ambien, Lunesta, and Sonata 2Health News:Medicationdiscountcard.com recognizes sleep awareness week with discounts on sleep meds including Ambien, Lunesta, and Sonata 3Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 2Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 3Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 4Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 5Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 6
(Date:3/3/2015)... 3, 2015  Michigan brothers Dominique Larkin , 23, ... right ventricular dysplasia, or ARVD, a disease that causes irregular ... among young athletes. In 2007, doctors discovered the ... They later tested Dominique and found his "condition was just ... 2015 story in The Ann Arbor News , part ...
(Date:3/3/2015)... 2015 Research and Markets ( ... "Global Ultrasound Equipment Market 2015-2019" report ... The Global Ultrasound Equipment market to grow at ... Ultrasound equipment are used to examine ... extensively used by cardiologists, radiologists, surgeons, obstetricians, and ...
(Date:3/3/2015)...   VWR  (NASDAQ:  VWR), a leading, independent ... today the expansion of its distribution agreement with ... VWR increased access to NEB,s growing product portfolio ... Puerto Rico.  In addition, customers will now have ... sales organization, and VWRCATALYST, our onsite services organization. ...
Breaking Medicine Technology:Younger of 2 Brothers on the SynCardia Total Artificial Heart Gets a Donor Heart Transplant 2Younger of 2 Brothers on the SynCardia Total Artificial Heart Gets a Donor Heart Transplant 3Global Ultrasound Equipment Market 2015-2019: Rise in Number of MI Diagnostic Procedures with GE Healthcare, Phillips Healthcare, Siemens Healthcare & Toshiba Medical Systems Dominating 2VWR Announces Expansion of Distribution Agreement with New England Biolabs 2
Cached News: